A clinical trial to evaluate AZD7648 alone and in combination with other anti-cancer agents in patients with advanced cancers.

Trial Identifier: D9170C00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT03907969
Start Date: October 2019
Primary Completion Date: December 2022
Study Completion Date: December 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
English (UK) Translation

Trial Locations